Covenant Multifamily Offices’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1.61M Buy
19,752
+1,490
+8% +$113K 0.29% 62
2021
Q2
$1.42M Sell
18,262
-533
-3% -$39.6K 0.26% 71
2021
Q1
$1.38M Buy
18,795
+14,269
+315% +$1.05M 0.28% 64
2020
Q4
$353K Buy
4,526
+1,083
+31% +$82.8K 0.06% 101
2020
Q3
$272K Sell
3,443
-6,006
-64% -$470K 0.05% 101
2020
Q2
$697K Buy
9,449
+3,480
+58% +$262K 0.14% 78
2020
Q1
$438K Sell
5,969
-69
-1% -$5.42K 0.11% 77
2019
Q4
$515K Buy
6,038
+504
+9% +$41.4K 0.09% 133
2019
Q3
$445K Sell
5,534
-2,242
-29% -$180K 0.1% 110
2019
Q2
$622K Buy
+7,776
New +$595K 0.14% 90

Other funds holding MRK

Covenant Multifamily Offices's MRK Position: Q3 2021 in Review

Covenant Multifamily Offices increased its Merck (MRK) stake by 8.2% in Q3 2021, buying an estimated $113K and bringing the position to 19,752 shares worth $1.61M. The position accounts for 0.29% of the portfolio, ranked #62.

Covenant Multifamily Offices first reported a position in MRK in Q2 2019 and has held it in 10 quarters since. 2,648 funds tracked by Wall St. Rank hold MRK as of Q3 2021.

  • Covenant Multifamily Offices held 19,752 shares of Merck worth $1.61M as of Q3 2021.
  • Covenant Multifamily Offices bought 1,490 Merck shares in Q3 2021, an estimated $113K.
  • Merck made up 0.29% of Covenant Multifamily Offices's portfolio in Q3 2021, its #62 holding.
  • Covenant Multifamily Offices first reported a position in Merck in Q2 2019 and has held it in 10 quarters since.
  • 2,648 funds tracked by Wall St. Rank held Merck as of Q3 2021.

Based on Covenant Multifamily Offices's 13F filing for Q3 2021, filed 21 Oct 2021.